What condition is Relvar Ellipta indicated to treat regularly in adults and adolescents aged 12 years and older?

Relvar Ellipta is indicated for regular asthma treatment in adults and adolescents aged 12 years and older when an inhaled corticosteroid/long-acting beta2-agonist combination is appropriate: patients inadequately controlled with inhaled corticosteroids and as-needed inhaled short-acting beta2-agonists, or already adequately controlled with inhaled corticosteroids and a long-acting beta2-agonist.